Review article · 2025 · Open access
Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery
Advanced Drug Delivery Reviews, 229, 115762 · Published 18 December 2025 · DOI 10.1016/j.addr.2025.115762
In brief
“Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery” is a 2025 review article by Nazreen Pallikkavaliyaveetil and Sriram Chandrasekaran, published in Advanced Drug Delivery Reviews. OpenAlex counts 62 citations as of 16 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Advanced Drug Delivery Reviews.
- Citations
- 62
- Most cited in
- 2026 (62)
- Field-weighted impact
- 3.06
- References
- 227
- Authors
- 2
Abstract
A critical bottleneck limiting the potential of Machine Learning (ML) and Deep Learning (DL) models within the drug discovery and development (DDD) pipeline is the scarcity of high-quality experimental data. Limited data is not an anomaly but an inherent characteristic of the DDD process. Significant financial costs, time, and confidentiality concerns limit the scale of available datasets. Applying standard ML and DL algorithms directly to these small datasets presents substantial challenges. Traditional ML models remain constrained by their dependence on handcrafted features and limited ability to capture complex biological relationships. In contrast, DL algorithms that assume data abundance are prone to overfitting and poor generalization when trained on small datasets. The small data problem thus represents a fundamental constraint that shapes the practical utility and trustworthiness of AI applications in DDD. While prior reviews have surveyed the broad landscape of AI and ML in drug discovery, a significant gap exists concerning the small data challenge across the DDD pipeline. Addressing this challenge requires adapting DL methods that typically assume data abundance, while also extending traditional ML approaches that, although well-suited to small data, remain limited in their representational capacity. This review addresses this gap by surveying key drug discovery tasks, highlighting the prevalence of limited data, and synthesizing both traditional ML methods and advanced DL strategies tailored to these contexts. By integrating methodological advances with task-specific applications, the review outlines current approaches and identifies opportunities for advancing robust, interpretable, and generalizable AI in drug discovery.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pallikkavaliyaveetil, N., & Chandrasekaran, S. (2025). Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery. Advanced Drug Delivery Reviews, 229, 115762. https://doi.org/10.1016/j.addr.2025.115762
MLA 9
Pallikkavaliyaveetil, Nazreen, and Sriram Chandrasekaran. “Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery.” Advanced Drug Delivery Reviews, vol. 229, 2025, p. 115762. https://doi.org/10.1016/j.addr.2025.115762.
Chicago
Pallikkavaliyaveetil, Nazreen and Sriram Chandrasekaran. 2025. “Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery.” Advanced Drug Delivery Reviews 229: 115762. https://doi.org/10.1016/j.addr.2025.115762.
Harvard
Pallikkavaliyaveetil, N. and Chandrasekaran, S. (2025) ‘Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery’, Advanced Drug Delivery Reviews, 229, p. 115762. doi:10.1016/j.addr.2025.115762.
IEEE
N. Pallikkavaliyaveetil and S. Chandrasekaran, “Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery,” Advanced Drug Delivery Reviews, vol. 229, p. 115762, 2025, doi: 10.1016/j.addr.2025.115762.
BibTeX
@article{pallikkavaliyaveetil2025small,
title = {{Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery}},
author = {Pallikkavaliyaveetil, Nazreen and Chandrasekaran, Sriram},
journal = {Advanced Drug Delivery Reviews},
year = {2025},
volume = {229},
pages = {115762},
doi = {10.1016/j.addr.2025.115762},
url = {https://doi.org/10.1016/j.addr.2025.115762}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- small data
- machine learning
- deep learning
- overfitting
- generalization
- drug discovery pipeline
- data scarcity
- explainable AI
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Pallikkavaliyaveetil, N., & Chandrasekaran, S. (2025). Small data, big challenges: Machine- and deep-learning strategies for data-limited drug discovery. Advanced Drug Delivery Reviews, 229, 115762. https://doi.org/10.1016/j.addr.2025.115762
How many times has this paper been cited?
62 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Advanced Drug Delivery Reviews: sign in and open the full text from this page.
Who wrote this paper?
Nazreen Pallikkavaliyaveetil, Sriram Chandrasekaran.
What is the DOI of this paper?
10.1016/j.addr.2025.115762, permanently at https://doi.org/10.1016/j.addr.2025.115762. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.